Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease

被引：4
|
作者：
Fumery, M. [1 ]
Peyrin-biroulet, L. [2 ]
Nancey, S. [3 ]
Altwegg, R. [4 ]
Veyrard, P. [5 ]
Bouguen, G. [6 ]
Viennot, S. [7 ]
Poullenot, F. [8 ]
Filippi, J. [9 ]
Buisson, A.
Bozon, A. [10 ]
Gilletta, C. [11 ]
Brazier, F. [1 ]
Pouillon, L. [2 ]
Flourie, B. [12 ]
Boivineau, L. [4 ]
Siproudhis, L. [6 ]
Laharie, D. [8 ]
Roblin, X. [5 ]
Treton, X. [10 ]
机构：
[1] Amiens Univ Hosp, Gastroenterol, F-80000 Amiens, France
[2] Nancy Univ Hosp, Gastroenterol, Nancy, France
[3] Lyon Univ Hosp, Lyon, France
[4] Montpellier Univ Hosp, Gastroenterol, Montpellier, France
[5] St Etienne Univ Hosp, Gastroenterol, St Etienne, France
[6] Rennes Univ Hosp, Gastroenterol, Rennes, France
[7] Caen Univ Hosp, Gastroenterol, Caen, France
[8] Bordeaux Univ Hosp, Gastroenterol, Bordeaux, France
[9] Nice Univ Hosp, Gastroenterol, Nice, France
[10] Hop Beaujon, Gastroenterol, Clichy, France
[11] Toulouse Univ Hosp, Gastroenterol, Toulouse, France
[12] Lyon Univ Hosp, Gastroenterol, Lyon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP24
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study
    Fumery, Mathurin
    Peyrin-Biroulet, Laurent
    Nancey, Stephane
    Altwegg, Romain
    Gilletta, Cyrielle
    Veyrard, Pauline
    Bouguen, Guillaume
    Viennot, Stephanie
    Poullenot, Florian
    Filippi, Jerome
    Buisson, Anthony
    Bozon, Anne
    Brazier, Franck
    Pouillon, Lieven
    Flourie, Bernard
    Boivineau, Lucile
    Siproudhis, Laurent
    Laharie, David
    Roblin, Xavier
    Diouf, Momar
    Treton, Xavier
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (02): : 222 - 227
  • [2] Ustekinumab 90 mg Every 2 Weeks for the Treatment of Inflammatory Bowel Disease
    Storan, Darragh
    Doherty, Glen A.
    Cullen, Garret
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1502 - 1502
  • [3] Assessing the safety and effectiveness of 4 weekly Ustekinumab in Crohn's disease
    Sewell, Charlotte
    Cooney, Rachel
    [J]. GUT, 2023, 72 (SUPPL_2) : A113 - A113
  • [4] Safety and effectiveness of ustekinumab in elderly Crohn's disease patients
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Conley, Thomas E.
    Townsend, Tristan
    Davies, Mike
    Brockwell, Robert
    Baig, Daniyal
    Abdelbadiee, Sherif
    Uney, Anastasia
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1132 - 1139
  • [5] Ustekinumab in Crohn's disease: effectiveness and safety in clinical practice
    Saldana Duenas, Cristina
    Rullan Iriarte, Maria
    Elosua Gonzalez, Alfonso
    Rodriguez Gutierrez, Cristina
    Rubio Iturria, Saioa
    Nantes Castillejo, Oscar
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (09): : 497 - 505
  • [6] Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks
    Chateau, Thomas
    Peyrin-Biroulet, Laurent
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : E7 - E7
  • [7] SAFETY AND EFFECTIVENESS OF 52-WEEKS USE OF USTEKINUMAB FOR CROHN'S DISEASE IN POSTMARKETING SURVEILLANCE STUDY IN JAPAN: EFFECTIVENESS FOR PERIANAL DISEASE
    Matsumoto, Takayuki
    Nagano, Katsumasa
    Hata, Erina
    Asano, Teita
    Tsuchiya, Hiroaki
    Takagishi, Masayuki
    Yamazaki, Hiroshi
    Tominaga, Sonoko
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1090 - S1090
  • [8] EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE IN ROUTINE CLINICAL PRACTICE
    Lynn, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Jairath, Vipul
    Kochhar, Gursimran
    Weiss, Aaron
    Phipps, Meaghan
    Agrawal, Mansi
    Click, Benjamin H.
    Meserve, Joseph
    Swaminath, Arun
    Bohm, Matthew
    Sagi, Sashidhar
    Fischer, Monika
    Hudesman, David
    Chang, Shannon
    Lawlor, Garrett
    Lukin, Dana J.
    Ullman, Thomas A.
    Boland, Brigid S.
    Singh, Siddharth
    Sandborn, William J.
    Regueiro, Miguel D.
    Shen, Bo
    Kane, Sunanda V.
    Loftus, Edward V.
    Dulai, Parambir S.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S885 - S885
  • [9] Infliximab 10 mg/kg Every 3 Weeks for Crohn's Disease
    Pillot, Claire
    Chevaux, Jean-Baptiste
    Bigard, Marc-Andre
    Peyrin-Biroulet, Laurent
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (11): : 2509 - 2510
  • [10] COMPARATIVE SAFETY AND EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY CROHN'S DISEASE PATIENTS
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy
    Davies, Mike
    Baig, Daniyal
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip
    Subramanian, Sreedhar
    [J]. GUT, 2022, 71 : A47 - A48
12345